A selenized tanshinone IIA derivative and an electrochemical synthesis method thereof

Selective direct C-H selenization at the C-16 site of tanshinone IIA was solved by electrochemical synthesis, and the problem of insufficient enhancement characteristics of tanshinone IIA was achieved efficiently and selectively constructed anti-tumor active selenization derivatives, simplifying the The synthesis steps are used and the cost is reduced, providing a green synthesis method.

CN118754926BActive Publication Date: 2024-11-22JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411237209.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-22
Estimated Expiration
2044-09-05

AI Technical Summary

Technical Problem

Tanshinone IIA's drug enhancement characteristics are insufficient, which limits its further development in clinical applications, especially since traditional synthesis methods require metal reagents, oxidants and highly toxic chemical reagents, the reaction conditions are harsh, the steps are numerous and the selectivity is poor.

Method used

Using a green, gentle and efficient electrochemical synthesis method, selective direct C-H selenization at the C-16 site of tanshinone IIA, and using clean electrons as oxidizing agents, avoiding the use of metal catalysts and highly toxic agents. A highly efficient and highly selective selenization reaction is achieved.

Benefits of technology

Achieve efficient and selective construction of selenized tanshinone class IIA derivatives, which have potential anti-tumor effects, simplify synthesis steps, reduce costs, and control reaction selectivity under mild conditions, providing a methodology for green synthesis refer to.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118754926B_ABST
    Figure CN118754926B_ABST
Patent Text Reader

Abstract

The present invention discloses a selenized tanshinone IIA derivative and an electrochemical synthesis method thereof, which adopts electrochemical oxidation technology and uses clean electrons as oxidants to achieve highly selective C-H bond activation of tanshinone IIA, a traditional Chinese medicine active ingredient, and a diselenide compound at the C-16 position, and synthesizes a series of selenized tanshinone IIA derivatives with potential anti-tumor activity. The synthesis method of the present invention has significant green chemical characteristics, avoids the use of expensive transition metal catalysts, excessive oxidants and highly toxic chemical reagents, and in addition, the method solves the problems of substrate pre-functionalization and multi-step reactions in traditional synthesis, and provides a synthesis route with mild conditions and controllable reaction process. More importantly, the electrochemical synthesis process can directly achieve Csp at the C-16 position. 2 The selective activation of ‑H bonds not only improves the synthesis efficiency, but also significantly enhances the application potential and industrial application value of this method.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of organic chemistry and medicinal chemistry, and in particular relates to a selenized tanshinone IIA derivative and an electrochemical synthesis method thereof. Background Art

[0002] Danshen belongs to the Lamiaceae family, and its dried rhizomes have been used as medicinal materials in traditional Chinese medicine for a long time. According to the 2020 edition of the Chinese Pharmacopoeia, Danshen not only has analgesic and hemostatic effects, but also promotes blood circulation and has a protective effect on the heart. Of particular note is that tanshinone IIA, a fat-soluble component in Danshen, is highly regarded for its low toxicity, significant therapeutic effects and good safety, as well as its wide range of pharmacological effects. These pharmacological effects include anti-tumor, anti-inflammatory, anti-ischemic, antioxidant and anti-thrombotic abilities, as well as their roles in inhibiting myocardial hypertrophy, promoting vasodilation, preventing atherosclerosis, and maintaining nerve cell integrity and microcirculatory function. Despite this, the insufficient drug-enhancing properties of tanshinone limit its further clinical application, limiting it from being an ideal lead compound for further structural modification and drug development.

[0003] At present, some research progress has been made on the structural modification of different reaction sites of Tanshinone IIA, especially the activation of C-16 position of D ring, which has a great influence on improving the activity of Tanshinone IIA. For example, the introduction of sodium sulfonate to the C-16 position resulted in the clinical use of Tanshinone IIA sodium sulfonate for the treatment of cardiovascular diseases. In recent years, the introduction of halogens into Tanshinone IIA or the reaction with sulfonyl chloride to obtain Tanshinone IIA compounds containing sulfonyl chloride groups, and then reacting with nucleophilic reagents to achieve activation of C-16 position (such as Figure 2 ), which has greatly improved the research on its anti-tumor activity. However, these activation processes often require the participation of metal reagents, equivalent oxidants and highly toxic chemical reagents. The limited substrate range, harsh reaction conditions, many by-products and many steps are still problems that need to be solved, which seriously restricts the further clinical application of tanshinone IIA compounds.

[0004] Organic electrochemical synthesis uses cheap, readily available and intrinsically safe electrons as redox reagents, and produces active intermediates through the reaction of compounds on the electrode surface to achieve efficient conversion, which solves the problem that traditional synthesis reactions require expensive transition metal catalysts and equivalent redox reagents. In addition, electrochemistry has a wide range of controllable redox potentials, which can well control the selectivity of the reaction. At present, the understanding of the field of electrochemical modification of tanshinone is relatively limited and needs further research. Summary of the invention

[0005] The purpose of the present invention is to provide a selenized tanshinone IIA derivative and an electrochemical synthesis method thereof, wherein the derivative has an anti-tumor effect. The present invention also provides a green, mild, and efficient modular electrochemical oxidation method, which can efficiently and selectively realize the selenization reaction of tanshinone IIA, solve the problem of multiple synthesis steps and harsh reaction conditions of tanshinone IIA derivatives, and provide ideas and methodological references for the research and development of green and inexpensive synthesis of tanshinone IIA derivatives.

[0006] The present invention proposes a C-16 site-selective direct CH selenization method for the electro-organic synthesis of tanshinone skeletons, which is not only efficient but also highly selective. This reaction exhibits several significant advantages: (a) it can be carried out without the use of metal catalysts or highly toxic chemical reagents; (b) electrons are used as the only oxidant, thus avoiding the need for stoichiometric oxidants; (c) the reaction is carried out at room temperature, the conditions are mild, the target product can be obtained in one step, and the step economy is high; (d) it achieves CH bond activation with extremely high chemical selectivity.

[0007] The technical solution of the present invention is as follows:

[0008] A selenized tanshinone IIA derivative, which uses tanshinone IIA, a fat-soluble extract of traditional Chinese medicine danshen, as the parent core structure, and introduces different selenium functional groups at its C-16 position. Its chemical structure is as follows:

[0009] ,

[0010] Wherein, R is selected from: phenyl, p-tolyl, p-ethylphenyl, p-tert-butylphenyl, p-isopropylphenyl, m-tolyl, o-tolyl, p-fluorophenyl, p-chlorophenyl, p-bromophenyl, m-fluorophenyl, m-chlorophenyl, m-bromophenyl, o-chlorophenyl, p-cyanophenyl, p-trifluoromethylphenyl, 2-naphthyl, methyl, any one of ethyl.

[0011] Specifically, the selenized tanshinone IIA derivative is selected from the following structural formula:

[0012] .

[0013] The present invention also provides an electrochemical synthesis method for selenized tanshinone IIA derivatives. The electrochemical synthesis method uses tanshinone IIA and diselenide compounds as starting materials, clean electrons as oxidants, and tetrabutylammonium tetrafluoroborate as electrolyte. Under electrochemical conditions, the diselenide compounds are oxidized at the anode to generate selenium free radicals, and the selenium free radicals undergo free radical addition with the C=C double bond of tanshinone IIA to generate carbon free radical intermediates. The intermediates are sequentially subjected to single-electron anode oxidation and proton elimination to obtain the target product.

[0014] The specific steps of the electrochemical synthesis method are: in an electrolytic cell, an anode and a cathode are set, tanshinone IIA, a diselenide compound, an electrolyte and a solvent are added in sequence, and the reaction is carried out under constant current conditions. After the reaction is completed, the reaction liquid is collected to obtain a selenized tanshinone IIA derivative.

[0015] Preferably, the molar ratio of the tanshinone IIA, the diselenide compound and the electrolyte is 1:1:1, the electrolyte is tetrabutylammonium tetrafluoroborate, and the solvent is acetonitrile.

[0016] Preferably, the chemical structural formula of Tanshinone IIA is: .

[0017] The chemical structure of the diselenide compound is generally expressed as RSeSeR, which is selected from the group consisting of diphenyl diselenide, 1,2-di-p-tolyl diselenide, 1,2-di-p-ethylphenyl diselenide, 1,2-di-p-tert-butylphenyl diselenide, 1,2-di-p-isopropylphenyl diselenide, 1,2-di-m-tolyl diselenide, 1,2-di-o-tolyl diselenide, 1,2-di-p-fluorophenyl diselenide, 1,2-di-p-chlorophenyl diselenide, 1,2-di-p-bromophenyl diselenide, 1,2-di-m-fluorophenyl diselenide, 1,2-di-m-chlorophenyl diselenide, 1,2-di-m-bromophenyl diselenide, 1,2-di-o-chlorophenyl diselenide, 1,2-di-p-cyanophenyl diselenide, 1,2-di-p-trifluoromethylphenyl diselenide, 1,2-bis(2-naphthyl) diselenide, dimethyl diselenide, and diethyl diselenide.

[0018] Wherein, R represents different substituents in the structure of the diselenide compound and is consistent with the general chemical structure formula of the selenized tanshinone IIA derivative. For example, when the diselenide compound is diphenyl diselenide, R is phenyl.

[0019] Preferably, the anode is a carbon rod, and the cathode is a platinum sheet.

[0020] Preferably, the constant current is 18-24 mA and the reaction time is 6-10 h.

[0021] Preferably, in the above-mentioned electrochemical synthesis method, after the reaction is completed, the reaction solution is concentrated and purified by column chromatography to obtain a selenized tanshinone IIA derivative, and the column chromatography conditions are: petroleum ether / ethyl acetate = 500 / 1, volume ratio.

[0022] The general reaction formula of the electrochemical synthesis is as follows:

[0023] .

[0024] The reaction mechanism of the electrochemical synthesis of the present invention is as follows:

[0025] First, under electrochemical conditions, diselenide compounds are preferentially oxidized at the anode to produce radical cation intermediate A, and then the intermediate decomposes into selenium radical B and selenium cation C. Selenium cation C is reduced to diselenide compounds at the cathode to participate in the next cycle. Next, selenium radical B undergoes radical addition with the C=C double bond at the C-16 position of tanshinone IIA to obtain carbon radical intermediate D, and intermediate D further loses electrons through anodic oxidation to obtain carbon cation intermediate E. Finally, carbon cation intermediate E loses a proton to obtain a selenized tanshinone IIA derivative. At the cathode, the proton gains electrons to produce hydrogen.

[0026] The present invention also provides the use of the selenized tanshinone IIA derivative in the preparation of anti-tumor drugs.

[0027] Preferably, the present invention provides the use of the selenized tanshinone IIA derivative in the preparation of anti-lung cancer drugs. More preferably, the selenized tanshinone IIA derivative can be specifically used to prepare anti-human non-small cell lung cancer cell A549 drugs.

[0028] The present invention also provides a pharmaceutical preparation, which comprises the selenized tanshinone IIA derivative and one or more pharmaceutically acceptable carriers or excipients.

[0029] Beneficial effects of the present invention:

[0030] 1. The selenized tanshinone IIA derivatives obtained by the present invention have the effect of inhibiting lung cancer cells and have potential anti-lung cancer effects.

[0031] 2. The present invention uses electrochemical oxidation and clean electrons as oxidizing agents. In the absence of metals, exogenous oxidants and highly toxic chemical reagents, it achieves the selective activation of tanshinone IIA and diselenide, a fat-soluble extract of the traditional Chinese medicine Salvia miltiorrhiza, and constructs a series of selenized tanshinone IIA derivatives with high selectivity and efficiency.

[0032] 3. The present invention solves the problems of the traditional synthesis of active molecules of tanshinone IIA compounds, which has many steps, harsh reaction conditions, difficult synthesis routes, and the need for pre-functional group activation of substrates. It can also avoid the use of a large amount of expensive transition metal catalysts and equivalent oxidizing agents in the synthesis process. Most importantly, this method can well control the site selectivity of the reaction under mild conditions, providing ideas and methodological references for the research and development of green and inexpensive synthesis of tanshinone IIA derivatives. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 The general chemical structure formula of the selenized tanshinone IIA derivative prepared by the present invention;

[0034] Figure 2 The present invention is a method for activating the C-16 position of the tanshinone IIA raw material by structural modification in the prior art;

[0035] Figure 3 This is the reaction mechanism of the electrochemical synthesis of the present invention. DETAILED DESCRIPTION

[0036] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0037] Unless otherwise specified, the reagents involved in the embodiments of the present invention are all commercially available products and can be purchased through commercial channels.

[0038] The present invention provides an electrochemical synthesis method of tanshinone IIA derivatives, and its reaction mechanism is shown in Figure 3 The general structural formula of the selenized tanshinone IIA derivatives is shown in Figure 1 .

[0039] 1. Electrochemical Synthesis of Compounds

[0040] Example 1 Synthesis of Compound 1

[0041]

[0042] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), diphenyl diselenide (0.3 mmol, 93.6 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 98.8 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0043] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 1) with an isolation yield of 92%.

[0044] 1 H NMR (400 MHz, CDCl3) d 7.58 (q, 2H, J 1 = 8.0 Hz, J 2= 20.0 Hz),7.37-7.36 (m, 2H), 7.27-7.22 (m, 3H), 3.16 (t, 2H, J = 8.0 Hz), 2.36 (s, 3H), 1.81-1.75 (m, 2H), 1.66-1.63 (m, 2H), 1.30 (s, 6H).

[0045] 13 C NMR (101 MHz, CDCl3) d 37.80, 34.74, 31.84, 29.95, 19.11, 10.91.

[0046] HRMS (ESI) calculation for C 25 H 22 O3Se: 451.0809 (M+H + ), found: 451.0805.

[0047] Example 2 Synthesis of Compound 2

[0048]

[0049] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-di-p-tolyl diselenide (0.3 mmol, 102.1 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 98.8 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0050] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (compound 2) with an isolation yield of 43%.

[0051] 1 H NMR (400 MHz, CDCl3) d 7.52 (q, 2H, J 1= 8.0 Hz, J 2 = 12.0 Hz),7.22(d, 2H, J = 8.0 Hz),7.00 (d, 2H, J = 8.0 Hz), 3.10 (t, 2H, J = 8.0 Hz), 2.29 (s, 3H), 2.22 (s, 3H), 1.75-1.70 (m, 2H), 1.59-1.56 (m, 2H), 1.23 (s, 6H).

[0052] 13 C NMR (101 MHz, CDCl3) d 9.85, 36.77, 33.69, 30.80, 28.91, 20.03, 18.07, 9.85.

[0053] HRMS (ESI) calculation for C 26 H 24 O3Se: 465.0965 (M+H + ), found: 465.0957.

[0054] Example 3 Synthesis of Compound 3

[0055]

[0056] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-di-p-ethylphenyl diselenide (0.3 mmol, 102.1 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 98.8 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0057] (2) After the reaction, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (compound 3) with an isolation yield of 20%.

[0058] 1 H NMR (400 MHz, CDCl3) d 7.62 (q, 2H, J 1 = 8.0 Hz, J 2 = 12.0 Hz),7.32 (d, 2H, J = 8.0 Hz),7.10 (d, 2H, J = 8.0 Hz), 3.18 (t, 2H, J = 8.0 Hz),2.60 (q, 2H, J 1 = 8.0 Hz, J 2 = 12.0 Hz), 2.37 (s, 3H), 1.80-1.78 (m, 2H), 1.67-1.64 (m, 2H), 1.30 (s, 6H), 1.20 (t, 3H, J = 8.0 Hz).

[0059] 13 C NMR (101 MHz, CDCl3) d 37.81, 34.73, 31.84, 29.95, 28.45, 19.11, 15.45,10.89.

[0060] HRMS (ESI) calculation for C 27 H 26 O3Se: 501.0941 (M+Na + ), found:501.0945.

[0061] Example 4 Synthesis of Compound 4

[0062]

[0063] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-di-p-tert-phenyl diselenide (0.3 mmol, 102.1 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 98.8 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0064] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (compound 4) with an isolation yield of 18%.

[0065] 1 H NMR (400 MHz, CDCl3) d 7.63 (t, 2H, J = 8.0 Hz), 7.31 (q, 4H, J 1 =8.0 Hz, J 2 = 16.0 Hz) , 3.18 (t, 2H, J = 8.0 Hz), 2.38 (s, 3H), 1.82-1.76 (m, 2H), 1.67-1.65 (m, 2H), 1.31 (s, 6H), 1.28 (s, 9H).

[0066] 13 C NMR (101 MHz, CDCl3) d 37.81, 34.73, 34.57, 31.84, 31.21, 29.95, 19.11, 10.94.

[0067] HRMS (ESI) calculation for C 29 H 30 O3Se: 529.1255 (M+Na + ), found:529.1262.

[0068] Example 5 Synthesis of Compound 5

[0069]

[0070] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-diisopropylphenyl diselenide (0.3 mmol, 111.7 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0071] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (compound 5) with an isolation yield of 54%.

[0072] 1 H NMR (400 MHz, CDCl3) d 7.60 (q, 4H, J 1 = 8.0 Hz, J 2 = 12.0 Hz),7.32(d, 2H, J = 8.0 Hz),7.12 (d, 2H, J = 8.0 Hz), 3.17 (t, 2H, J = 8.0 Hz), 2.90-2.80 (m, 1H), 2.37 (s, 3H), 1.80-1.77 (m, 2H), 1.67-1.64 (m, 2H), 1.30 (s, 6H), 1.21 (s, 3H), 1.20 (s, 3H).

[0073] 13 C NMR (101 MHz, CDCl3) d 37.81, 34.73, 33.76, 31.84, 29.95, 23.87, 19.11, 10.93.

[0074] HRMS (ESI) calculation for C 28 H 28 O3Se: 483.0810 (M+Na + ), found: 483.0812.

[0075] Example 6 Synthesis of Compound 6

[0076]

[0077] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-dimethylphenyl diselenide (0.3 mmol, 134.4 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0078] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 6) with an isolation yield of 42%.

[0079] 1 H NMR (400 MHz, CDCl3) d 7.54 (q, 2H, J 1 = 8.0 Hz, J 2 = 16.0 Hz),7.13-7.06 (m, 2H),7.03 (d, 1H, J = 8.0 Hz), 6.98-6.94 (m, 2H), 3.12 (t, 2H, J = 8.0 Hz), 2.39 (s, 3H), 2.28 (s, 3H), 1.74-1.71 (m, 2H), 1.60-1.57 (m, 2H), 1.23 (s, 6H).

[0080] 13 C NMR (101 MHz, CDCl3) d36.77, 33.71, 30.80, 28.92, 20.68, 18.07,9.82.

[0081] HRMS (ESI) calculation for C 26 H 24 O3Se: 465.0965 (M+H + ), found: 465.0957.

[0082] Example 7 Synthesis of Compound 7

[0083]

[0084] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-di-o-tolyl diselenide (0.3 mmol, 104.4 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0085] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 7) with an isolation yield of 16%.

[0086] 1 H NMR (400 MHz, CDCl3) d 7.54 (q, 2H, J 1 = 8.0 Hz, J 2 = 12.0 Hz),7.12(s, 1H), 7.08-7.04 (m, 2H), 6.99-6.96 (m, 1H), 3.11 (t, 2H, J= 8.0 Hz), 2.30 (s, 3H), 2.22 (s, 3H), 1.75-1.70 (m, 2H), 1.59-1.57 (m, 2H), 1.23 (s, 6H).

[0087] 13 C NMR (101 MHz, CDCl3) d 36.77, 33.70, 30.80, 28.91, 20.35, 18.06,9.88, 127.25, 126.57, 126.51,125.88, 125.65, 119.79, 119.50, 36.77, 33.70, 30.80, 28.91, 20.35, 18.06,9.88.

[0088] HRMS (ESI) calculation for C 26 H 24 O3Se: 465.0965 (M+H + ), found: 465.0953.

[0089] Example 8 Synthesis of Compound 8

[0090]

[0091] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-di-p-fluorophenyl diselenide (0.3 mmol, 104.4 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0092] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 8) with an isolation yield of 77%.

[0093] 1 H NMR (400 MHz, CDCl3) d 7.53 (q, 2H, J 1 = 8.0 Hz, J 2= 20.0 Hz),7.35-7.30 (m, 2H), 6.89 (t, 2H, J = 8.0 Hz), 3.09 (t, 2H, J = 8.0 Hz), 2.29 (s, 3H), 1.74-1.69 (m, 2H), 1.59-1.56 (m, 2H), 1.22 (s, 6H).

[0094] 13 C NMR (101 MHz, CDCl3) d 181.98, 173.99, 162.89, 161.49 (d, J =249.47 Hz), 149.84, 143.64, 140.06, 132.49, 132.22 (d, J = 8.08 Hz), 128.79,125.75, 125.63, 123.60, 123.57, 119.72, 115.72 (d, J = 22.2 Hz), 36.74, 33.70, 30.79, 28.90, 18.04, 9.83.

[0095] 19 F NMR (376 MHz, CDCl3) d -113.77.

[0096] HRMS (ESI) calculation for C 25 H 21 O3FSe: 469.0714 (M+H + ), found:469.0710.

[0097] Example 9 Synthesis of Compound 9

[0098]

[0099] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-dichlorophenyl diselenide (0.3 mmol, 104.4 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0100] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 9) with an isolation yield of 91%.

[0101] 1 H NMR (400 MHz, CDCl3) d 7.55 (q, 2H, J 1 = 8.0 Hz, J 2 = 16.0 Hz),7.25-7.22 (m, 2H), 7.18-7.14 (m, 2H), 3.11 (t, 2H, J = 8.0 Hz), 2.30 (s, 3H), 1.74-1.70 (m, 2H), 1.60-1.58 (m, 2H), 1.24 (s, 6H).

[0102] 13 C NMR (101 MHz, CDCl3) d 33.73, 30.80, 28.93, 18.06, 9.85.

[0103] HRMS (ESI) calculation for C 25 H 21 O3ClSe: 485.0416 (M+H + ), found:485.0399.

[0104] Example 10 Synthesis of Compound 10

[0105]

[0106] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-di-p-bromophenyl diselenide (0.3 mmol, 141.0 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0107] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 10) with an isolation yield of 33%.

[0108] 1 H NMR (400 MHz, CDCl3) d 7.55 (q, 2H, J 1 = 8.0 Hz, J 2 = 16.0 Hz),7.25-7.22 (m, 2H), 7.18-7.14 (m, 2H), 3.11 (t, 2H, J = 8.0 Hz), 2.30 (s, 3H), 1.74-1.70 (m, 2H), 1.60-1.58 (m, 2H), 1.24 (s, 6H).

[0109] 13 C NMR (101 MHz, CDCl3) d 36.75, 33.73, 30.80, 28.93, 18.05, 9.85.

[0110] HRMS (ESI) calculation for C 25 H 21 O3BrSe: 528.9911 (M+H + ), found:528.9907.

[0111] Example 11 Synthesis of Compound 11

[0112]

[0113] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-difluorophenyl diselenide (0.3 mmol, 141.0 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0114] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 11) with an isolation yield of 44%.

[0115] 1 H NMR (400 MHz, CDCl3) d 7.62 (q, 2H, J 1 = 8.0 Hz, J 2 = 16.0 Hz),7.25-7.20 (m, 1H), 7.11 (d, 1H, J = 8.0 Hz), 7.04-7.01 (m, 1H), 6.95-6.90 (m, 1H), 3.18 (t, 2H, J = 8.0 Hz), 2.37 (s, 3H), 1.81-1.78 (m, 2H), 1.67-1.64 (m, 2H), 1.31 (s, 6H).

[0116] 13 C NMR (101 MHz, CDCl3) d 182.93, 174.98, 164.25, 151.03, 144.74,144.40, 133.56, 132.32 (d, J = 7.07 Hz), 130.92 (d, J = 13.13 Hz), 130.76,126.72, 126.70, 125.65, 125.62, 120.85, 120.46, 117.12 (d, J = 23.23 Hz),114.42 (d, J= 21.21 Hz), 37.78, 34.76, 31.83, 29.96, 19.09, 10.89.

[0117] 19 F NMR (376 MHz, CDCl3) d -110.80.

[0118] HRMS (ESI) calculation for C 25 H 21 O3FSe: 469.0714 (M+H + ), found:469.0712.

[0119] Example 12 Synthesis of Compound 12

[0120]

[0121] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-dichlorophenyl diselenide (0.3 mmol, 141.0 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0122] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 12) with an isolation yield of 37%.

[0123] 1 H NMR (400 MHz, CDCl3) d 7.62 (q, 2H, J 1 = 8.0 Hz, J 2 = 12.0 Hz),7.32(d, 1H, J = 4.0 Hz), 7.24-7.16 (m, 3H), 3.19 (t, 2H, J = 8.0 Hz), 2.38 (s, 3H), 1.83-1.78 (m, 2H), 1.67-1.65 (m, 2H), 1.31 (s, 6H).

[0124] 13C NMR (101 MHz, CDCl3) d 37.77, 31.84, 29.97, 19.09, 10.92.

[0125] HRMS (ESI) calculation for C 25 H 21 O3ClSe: 485.0416 (M+H + ), found:485.0421.

[0126] Example 13 Synthesis of Compound 13

[0127]

[0128] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-dibromophenyl diselenide (0.3 mmol, 114.3 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0129] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 13) with an isolation yield of 45%.

[0130] 1 H NMR (400 MHz, CDCl3) d 7.62 (q, 2H, J 1 = 8.0 Hz, J 2 = 12.0 Hz),7.49(d, 1H, J = 8.0 Hz), 7.37 (d, 1H, J = 8.0 Hz), 7.28-7.25 (m, 1H), 7.12 (t,1H, J= 8.0 Hz), 3.18 (t, 2H, J = 8.0 Hz), 2.38 (s, 3H), 1.83-1.78 (m, 2H), 1.67-1.64 (m, 2H), 1.31 (s, 6H).

[0131] 13 C NMR (101 MHz, CDCl3) d 37.79, 34.76, 31.84, 29.97, 19.09, 10.94, 128.77, 126.75, 123.41, 120.88, 120.47, 37.79, 34.76, 31.84, 29.97, 19.09, 10.94.

[0132] HRMS (ESI) calculation for C 25 H 21 O3BrSe: 528.9911 (M+H + ), found:528.9912.

[0133] Example 14 Synthesis of Compound 14

[0134]

[0135] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-dichlorophenyl diselenide (0.3 mmol, 114.3 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0136] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 14) with an isolation yield of 21%.

[0137] 1 H NMR (400 MHz, CDCl3) d 7.65 (q, 2H, J 1 = 8.0 Hz, J2 = 12.0 Hz),7.35(d, 1H, J = 8.0 Hz), 7.16 (t, 1H, J = 8.0 Hz), 7.08 (t, 1H, J = 8.0 Hz), 6.87(d, 1H, J = 8.0 Hz) 3.20 (t, 2H, J = 8.0 Hz), 2.37 (s, 3H), 1.82-1.79 (m, 2H), 1.68-1.65 (m, 2H), 1.31 (s, 6H).

[0138] 13 C NMR (101 MHz, CDCl3) d 5, 120.95, 120.55, 37.79, 34.79, 31.84, 29.98, 19.10, 10.87, 128.77,128.79, 128.83, 128.97, 128.84, 37.79, 34.79, 31.84, 29.98, 19.10, 10.87.

[0139] HRMS (ESI) calculation for C 25 H 21 O3ClSe: 507.0236 (M+Na + ), found: 507.0233.

[0140] Example 15 Synthesis of Compound 15

[0141]

[0142] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-di-p-cyanophenyl diselenide (0.3 mmol, 123.6 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0143] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 15) with an isolation yield of 30%.

[0144] 1 H NMR (400 MHz, CDCl3) d 7.63 (q, 2H, J 1 = 8.0 Hz, J 2 = 20.0 Hz),7.51(d, 2H, J = 12.0 Hz), 7.36 (d, 2H, J = 8.0 Hz), 3.20 (t, 2H, J = 8.0 Hz), 2.38 (s, 3H), 1.84-1.78 (m, 2H), 1.68-1.65 (m, 2H), 1.32 (s, 6H).

[0145] 13 C NMR (101 MHz, CDCl3) d 37.75, 34.81, 31.84, 29.99, 19.07, 10.89.

[0146] HRMS (ESI) calculation for C 26 H 21 NOSe: 476.0761 (M+H + ), found: 476.0759.

[0147] Example 16 Synthesis of Compound 16

[0148]

[0149] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-di-p-trifluoromethylphenyl diselenide (0.3 mmol, 123.6 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0150] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 16) with an isolation yield of 46%.

[0151] 1 H NMR (400 MHz, CDCl3) d 7.63 (q, 2H, J 1 = 12.0 Hz, J 2 = 16.0 Hz),7.50 (d, 2H, J = 8.0 Hz), 7.41 (d, 2H, J = 8.0 Hz), 3.19 (t, 2H, J = 8.0 Hz), 2.38 (s, 3H), 1.83-1.79 (m, 2H), 1.68-1.65 (m, 2H), 1.31 (s, 6H).

[0152] 13 C NMR (101 MHz, CDCl3) d 182.91, 174.99, 164.45, 151.18, 144.82,139.34, 135.91, 133.59, 131.45, 129.67, 129.44 (q, J 1 = 32.3 Hz, J 2 = 65.6 Hz),126.77, 126.63, 126.32 (q, J 1 = 4.0 Hz, J 2 = 8.1 Hz), 123.90 (q, J 1 = 272.7 Hz, J2 = 546.4 Hz), 120.87, 120.46, 37.76, 34.78, 31.83, 29.97, 19.08, 10.90.

[0153] 19 F NMR (376 MHz, CDCl3) d -62.69.

[0154] HRMS (ESI) calculation for C 26 H 21 O3FSe: 541.0502 (M+Na + ), found: 541.0485.

[0155] Example 17 Synthesis of Compound 17

[0156]

[0157] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), 1,2-bis(2-naphthyl) diselenide (0.3 mmol, 123.6 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0158] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 17) with an isolation yield of 34%.

[0159] 1 H NMR (400 MHz, CDCl3) d 7.86 (s, 2H),7.50 (q, 2H, J 1 = 8.0 Hz, J 2 =24.0 Hz), 7.63-7.53 (m, 2H),7.52 (s, 1H), 7.48-7.39 (m, 2H), 3.18 (t, 2H, J =8.0 Hz), 2.40 (s, 3H), 2.26 (s, 3H), 1.82-1.76 (m, 2H), 1.67-1.63 (m, 2H), 1.30 (d, 6H,J = 8.0 Hz).

[0160] 13 C NMR (101 MHz, CDCl3) d 8.5, 120.25, 37.80, 34.74, 31.83,29.96, 19.10, 10.95, 8.81.

[0161] HRMS (ESI) calculation for C 29 H 24 N2OSe: 501.0966 (M+H + ), found: 501.0965.

[0162] Example 18 Synthesis of Compound 18

[0163]

[0164] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), dimethyl diselenide (0.3 mmol, 56.4 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0165] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 18) with an isolation yield of 59%.

[0166] 1 H NMR (400 MHz, CDCl3) d 7.54 (q, 2H, J 1 = 8.0 Hz, J 2 = 16.0 Hz),3.10(t, 2H, J= 8.0 Hz), 2.23 (d, 6H, J = 8.0 Hz), 1.73-1.70 (m, 2H), 1.60-1.57 (m, 2H), 1.24 (s, 6H).

[0167] 13 C NMR (101 MHz, CDCl3) d 37.82, 34.70, 31.84,29.93, 19.11, 10.70, 9.17.

[0168] HRMS (ESI) calculation for C 20 H 20 O3Se: 389.0652 (M+H + ), found: 389.0654.

[0169] Example 19 Synthesis of Compound 19

[0170]

[0171] (1) In a 25 mL three-necked reaction tube equipped with a stirrer, a carbon rod was used as the anode and a platinum sheet was used as the cathode. Tanshinone IIA (0.3 mmol, 88.3 mg), diethyl diselenide (0.3 mmol, 64.8 mg), and electrolyte tetrabutylammonium tetrafluoroborate (0.3 mmol, 111.7 mg) were added in sequence. After argon was evacuated three times, acetonitrile was added and the reaction was carried out at a constant current of 21 mA for 8 h.

[0172] (2) After the reaction was completed, the reaction solution was concentrated and subjected to column chromatography (petroleum ether / ethyl acetate = 500 / 1, volume ratio) to obtain the pure selenized tanshinone IIA derivative (Compound 19) with an isolation yield of 87%.

[0173] 1 H NMR (400 MHz, CDCl3) d 7.63 (q, 2H, J 1 = 8.0 Hz, J 2 = 12.0 Hz),3.18(t, 2H, J= 8.0 Hz), 2.84 (q, 2H, J 1 = 8.0 Hz, J 2 = 16.0 Hz), 2.33 (s, 3H), 1.83-1.77 (m, 2H), 1.67-1.64 (m, 2H), 1.44 (t, 3H, J = 8.0 Hz), 1.31 (s, 6H).

[0174] 13 C NMR (101 MHz, CDCl3) d 37.83, 34.71, 31.85,29.94, 23.33, 19.11, 16.10, 10.90.

[0175] HRMS (ESI) calculation for C 21 H 22 O3Se: 403.0808 (M+H + ), found: 403.0811.

[0176] 2. Antitumor Activity Experiment of Compounds

[0177] The human lung adenocarcinoma cell line A549 was used to screen the anti-tumor activity of the selenized tanshinone IIA derivatives synthesized in Examples 1-19 of the present invention. A single cell suspension (concentration of 1.0×10 5 / mL), and inoculated in a 96-well plate. The 96-well plate was set up with a blank group (DMEM culture medium), a blank control group (DMEM culture medium and human lung adenocarcinoma A549 cell line) and an experimental group (DMEM culture medium, human lung adenocarcinoma A549 cell line and drugs). The raw material drug Tanshinone IIA of some compounds of the present invention was used as a positive inhibitor control. The test concentrations of Tanshinone IIA and compound 1-19 samples were both 10 μM. After the cells adhered to the wall, CCK8 was added, and the absorbance value was measured at a wavelength of 450 nm by setting the microplate reader to obtain the inhibition rate of each sample, as shown in Table 1 below.

[0178] Table 1

[0179]

[0180] As shown in Table 1, when the test concentration is 10 μM, the inhibition rate of each compound of the present invention on A549 cells is between 0% and 52%, compounds 5, 6, 14, and 15 do not show an inhibitory effect, and the remaining compounds obtained by the present invention have an inhibitory effect on A549 cells. Among them, the inhibition rates of compounds 8, 17, and 18 are improved compared with their parent core structure Tanshinone IIA, and the inhibition rate of compound 18 is significantly improved compared with the raw material Tanshinone IIA, indicating that modification based on the parent core structure of Tanshinone IIA is helpful to produce compounds with better anti-tumor activity.

[0181] Finally, it should be noted that the above is only a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A selenized tanshinone IIA derivative, characterized in that: The selenized tanshinone IIA derivatives are based on tanshinone IIA as the core structure, and different selenium-containing groups are introduced on the C-16 position thereof. The selenized tanshinone IIA derivatives are selected from the following structural formulas: 。 2. A method for electrochemical synthesis of selenized tanshinone IIA derivatives, characterized in that: The following steps are involved: In an electrolytic cell, an anode and a cathode are set, and tanshinone IIA, a diselenide compound, an electrolyte and a solvent are added in sequence, and reacted under constant current conditions. After the reaction is completed, the reaction liquid is collected to obtain a selenized tanshinone IIA derivative; The general chemical structure formula of the selenized tanshinone IIA derivative is: ; The structural formula of Tanshinone IIA is: ; The chemical structure formula of the diselenide compound is: RSeSeR; Wherein, R is selected from: any one of phenyl, p-tolyl, p-ethylphenyl, p-tert-butylphenyl, o-tolyl, p-fluorophenyl, p-chlorophenyl, p-bromophenyl, m-fluorophenyl, m-chlorophenyl, m-bromophenyl, 2-naphthyl, methyl, and ethyl.

3. The electrochemical synthesis method according to claim 2, characterized in that: The selenized tanshinone IIA derivative is selected from the following structural formula: 。 4. The electrochemical synthesis method according to claim 2, characterized in that: The molar ratio of the tanshinone IIA, the diselenide compound and the electrolyte is 1:1:1, the electrolyte is tetrabutylammonium tetrafluoroborate, and the solvent is acetonitrile.

5. The electrochemical synthesis method according to claim 2, characterized in that: The anode is a carbon rod, the cathode is a platinum sheet, the constant current is 18-24 mA, and the reaction time is 6-10 hours.

6. The electrochemical synthesis method according to claim 2, characterized in that: The electrochemical synthesis method further comprises: the reaction solution is concentrated and purified by column chromatography to obtain a selenized tanshinone IIA derivative, and the column chromatography conditions are: petroleum ether / ethyl acetate = 500 / 1, volume ratio.

7. The electrochemical synthesis method according to any one of claims 2 to 6, characterized in that: The electrochemical synthesis method uses tanshinone IIA and diselenide compounds as starting materials, clean electrons as oxidants, and tetrabutylammonium tetrafluoroborate as electrolytes. Under electrochemical conditions, the diselenide compounds are oxidized at the anode to generate selenium free radicals, and the selenium free radicals undergo free radical addition with the C=C double bond of tanshinone IIA to generate carbon free radical intermediates. The intermediates are sequentially subjected to single-electron anode oxidation and proton elimination to obtain the target product.

8. Use of the selenized tanshinone IIA derivative according to claim 1 in the preparation of anti-lung cancer drugs.

9. A pharmaceutical preparation, characterized in that: It comprises the selenized tanshinone IIA derivative according to claim 1, and one or more pharmaceutically acceptable carriers or excipients.